Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors
Description
Aim: Discovery of novel SARS-CoV-2 main protease (M^(pro)) inhibitors using a structure-based drug discovery strategy. Materials & methods: Virtual screening employing covalent and noncovalent docking was performed to discover M^(pro) inhibitors
